Poor physical function correlated with outcomes among patients with non-Hodgkin lymphoma who underwent chimeric antigen ...
Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma.
The FDA has approved Kite Pharma's Tecartus as a treatment for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL), making CAR-T therapy an option for an ...
Lucas Hunter loves to kite surf, so along with his sister Sophie he planned a trip to Colombia to take advantage of the “good waves” in the north of the country in late December last year.
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand ...
Story Jan. 10 - Shoreline Biosciences: The cell therapy biotech plans to let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly The U.S. Food and Drug Administration's chief ...
For 16 days this spring, an international kite festival will soar above the beaches of Cervia. Artenvento returns to northern Italy from April 19 to May 4 with more than 200 participants from 50 ...
After hours: March 14 at 5:05:00 PM EDT Loading Chart for KRG ...
What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...
As of 3:43:33 PM EDT. Market Open. Loading Chart for CART ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results